Clinical Trial Update: A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating efficacy, safety, and tolerability of mirabegron in men with overactive bladder who are taking an alpha-blocker for benign prostatic hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Myrbetriq (mirabegron)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Overactive Bladder | Phase 4 | Status: COMPLETED | Results posted: 2018-09-18